Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development.
Kim DDH, Popradi G, Lepic K, Paulson K, Allan D, Nampoothiri RV, Lachance S, Deotare U, White J, Elemary M, Jamani K, Fraga C, Lemieux C, Novitzky-Basso I, Law AD, Kumar R, Walker I, Schultz KR; CTTC Chronic GVHD Guideline Working Group. Kim DDH, et al. Among authors: deotare u. Curr Oncol. 2024 Mar 8;31(3):1426-1444. doi: 10.3390/curroncol31030108. Curr Oncol. 2024. PMID: 38534941 Free PMC article.
A Multicenter, Retrospective Study Evaluating Clinical Outcomes of Ruxolitinib Therapy In Heavily Pretreated Chronic GVHD Patients With Steroid Failure.
White J, Elemary M, Linn SM, Novitzky-Basso I, Culos S, Tan SK, Kelly K, Deotare U, Xenocostas A, Hamad N, Law A, Kumar R, Kim DDH. White J, et al. Among authors: deotare u. Transplant Cell Ther. 2023 Feb;29(2):120.e1-120.e9. doi: 10.1016/j.jtct.2022.11.025. Epub 2022 Nov 30. Transplant Cell Ther. 2023. PMID: 36460202 Free article. Clinical Trial.
Propensity score matching analysis comparing the efficacy of Ruxolitinib to historical controls in second-line or beyond treatment for chronic GvHD after steroid failure.
Novitzky-Basso I, Linn SM, White J, Elemary M, Xenocostas A, Deotare U, Kelly K, Hamad N, Tan S, Culos S, Law A, Kumar R, Mattsson J, Kim DDH. Novitzky-Basso I, et al. Among authors: deotare u. Bone Marrow Transplant. 2023 Sep;58(9):1024-1032. doi: 10.1038/s41409-023-02020-5. Epub 2023 Jun 26. Bone Marrow Transplant. 2023. PMID: 37365296
Reduction of severe acute graft-versus-host disease using a combination of pre transplant anti-thymocyte globulin and post-transplant cyclophosphamide in matched unrelated donor transplantation.
Deotare U, Atenafu EG, Loach D, Michelis FV, Kim DD, Thyagu S, Lipton JH, Messner HA, Viswabandya A. Deotare U, et al. Bone Marrow Transplant. 2018 Mar;53(3):361-365. doi: 10.1038/s41409-017-0053-9. Epub 2017 Dec 21. Bone Marrow Transplant. 2018. PMID: 29269806 No abstract available.
38 results